Showing results (81-90 of 1,644) with videos related to

Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|July 8, 2021
Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLSPaul Theron, Matthew Britland, Donna Holder, et al.
Therapeutic Innovation & Regulatory Science|July 20, 2021
Evaluating the Feasibility and Validity of a New Tool to Assess Organizational Preparedness and Capabilities to Support Patient Engagement in Drug DevelopmentDebra L Michaels, Yaritza Peña, Barbara Lopez Kunz, et al.
Therapeutic Innovation & Regulatory Science|July 28, 2021
Impact of Tumor Assessment Frequency on Statistical Power in Randomized Cancer Clinical Trials Evaluating Progression-Free SurvivalYuki Nakagawa, Takuya Yoshimoto, Shintaro Nakagawa, et al.
Therapeutic Innovation & Regulatory Science|September 26, 2018
Regulatory Trends in Drug Development in Asia PacificFengyun Vicky Han, Karen Weiss
Therapeutic Innovation & Regulatory Science|September 18, 2018
An Examination of eClinical Technology Usage and CDISC Standards AdoptionMary Jo Lamberti, Rebecca Kush, Wayne Kubick, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Considerations for Requiring Subjects to Provide a Response to Electronic Patient-Reported Outcome InstrumentsPaul O'Donohoe, J Jason Lundy, Ari Gnanasakthy, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Advances in the Evaluation of Longitudinal Construct Validity of Clinical Outcome AssessmentsValerie Williams, Lori McLeod, Lauren Nelson
Therapeutic Innovation & Regulatory Science|September 18, 2018
The Relationship Between Development Start Lag and Approval Lag in Oncology Drug Development in JapanKeitaro Nakajima, Ramzi Dagher, Laurie Strawn, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Analysis of Social Media Interactions Between Pharmaceutical Companies and Consumers: The Power of the "Like"William Jackson, Boas Park, Michael Toscani, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Confounding Issues in Cancer Progress-The Impact of Investor Requirements on Senior Management Compensation and Regulatory Decisions: Tivozanib and Aveo PharmaceuticalsJosephine C Babiarz, Francis Melaragni, Stephen Kerr, et al.
Pageof 165